| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 10/04/2006 | EP1706392A2 Pesticidal heterocyclic dihaloallyl compounds |
| 10/04/2006 | EP1706388A1 Therapeutic agents ii |
| 10/04/2006 | EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 10/04/2006 | EP1299389B1 A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence |
| 10/04/2006 | CN1842510A Fluorene-based derivative and organic electroluminescence device employing the same |
| 10/04/2006 | CN1840530A Process for preparing pemetrexed |
| 10/04/2006 | CN1277822C Quinazoline derivatives, pharmaceutical composition containing the compound, their utilization and preparation method thereof |
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/03/2006 | US7115768 Particularly (adamantylcarbonylamino)acetic acid derivatives |
| 10/03/2006 | US7115750 Melanin concentrating hormone antagonist |
| 10/03/2006 | US7115740 Pyrimido compounds having antiproliferative activity |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 10/03/2006 | US7115617 Anticarcinogenic and kinase inhibitor; a heteroaryl(containing atleast one oxygen or sulfur atom)amino substituted pyrimidine compound |
| 10/03/2006 | US7115616 Pyrimidinone compounds |
| 10/03/2006 | US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline |
| 10/03/2006 | US7115613 Compound of fused nitrogen containing heterocyclic ring, useful for treating prostate and angiogenic disorders |
| 10/03/2006 | US7115611 Phenyl derivatives, their manufacture and use as pharmaceutical agents |
| 10/03/2006 | US7115601 spirocycle-substituted pyrimidinecarboxamides such as N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(1,4,9-triazaspiro[5.5]undec-9-yl)-4-pyrimidinecarboxamide for treating HIV infection and AIDS |
| 10/03/2006 | US7115600 Histamine-3 receptor modulators |
| 10/03/2006 | US7115544 Plant growth regulators for cotton hervest |
| 10/03/2006 | US7115401 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
| 10/03/2006 | CA2474211C Antiproliferative quinazolines |
| 10/03/2006 | CA2277949C Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions |
| 10/03/2006 | CA2187130C Novel sulphonamides |
| 09/28/2006 | WO2006100689A1 Process for preparation of rosuvastatin |
| 09/28/2006 | WO2006100552A1 Processes for the preparation of lopinavir and its intermediate - (s)-tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2h)-pyrimidineacetic acid |
| 09/28/2006 | WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 09/28/2006 | WO2006100100A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 09/28/2006 | WO2006099974A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents |
| 09/28/2006 | WO2006044975A3 Compositions and their use as anti-tumor agents |
| 09/28/2006 | WO2006012577A3 Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake |
| 09/28/2006 | WO2005119315A3 Non-linear optically active molecules, their synthesis, and use |
| 09/28/2006 | WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds |
| 09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 09/28/2006 | US20060217552 Asymmetric alkynylation of ketone or ketimine, particularly, the enantioselective addition of terminal alkynes to trifluoromethyl ketone or ketimine intermediates to give a chiral tertiary proparglic alcohols or amines; precursors to the potent HIV reverse transcriptase inhibitor Efavirenz |
| 09/28/2006 | US20060217403 Substituted 2-aminoacetamides and the use thereof |
| 09/28/2006 | US20060217398 Substituted pyrimidine derivatives |
| 09/28/2006 | US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/28/2006 | DE102005027150A1 Pyrimidincarbonsäure-Derivate und ihre Verwendung Pyrimidinecarboxylic acid derivatives and their use |
| 09/28/2006 | DE102005014089A1 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 09/28/2006 | CA2598589A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 09/28/2006 | CA2598205A1 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 09/27/2006 | EP1705177A1 N-aryl-sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents |
| 09/27/2006 | EP1704144A1 A method of preparation of the hemi-calcium salt of (e)-7- [4-(4-fluorophenyl)-6-isopropyl-2- [me thyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxy-6-heptenoic acid |
| 09/27/2006 | EP1703909A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1335906B1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 09/27/2006 | EP1173222B1 Conjugate having a cleavable linkage for use in a liposome |
| 09/27/2006 | CN1839136A Pyrazolopyrimidines |
| 09/27/2006 | CN1276912C Uracil compounds and use thereof |
| 09/26/2006 | US7112674 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability |
| 09/26/2006 | US7112590 Anticoagulant for mammals |
| 09/26/2006 | US7112589 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 09/26/2006 | US7112585 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms |
| 09/26/2006 | CA2278694C Sulfamide-metalloprotease inhibitors |
| 09/21/2006 | WO2006099231A1 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/21/2006 | WO2006097391A1 Use of 2 -anilino - 3 , 4 -dihydro - quinazolines as 5ht5a receptor antagonists |
| 09/21/2006 | WO2006097220A1 Pyrimidine carboxylic acid derivatives and use thereof |
| 09/21/2006 | WO2006079556A3 Substituted 5-phenyl pyrimidines i in therapy |
| 09/21/2006 | WO2006067456A3 Process for preparing rosuvastatin |
| 09/21/2006 | WO2006066070A3 Prodrug constructs of pyrimidinone compounds as calcilytics |
| 09/21/2006 | WO2006065590A3 Pyridine and pyrimidine antiviral compositions |
| 09/21/2006 | US20060211863 Process for the preparation of opioid modulators |
| 09/21/2006 | US20060211862 Biotechnological resolution of racemic mixtures of 1-Amino-4-(hydroxymethyl)-2-cyclopentene using a hydrolase (lipase); optional formation of acyl derivatives |
| 09/21/2006 | US20060211719 Heteroaryl aminoguanidine and alkoxyguanidines and their use as protease inhibitors |
| 09/21/2006 | US20060211716 (3,4-Dihydro-quinazolin-2-yl)-aryl-amines |
| 09/21/2006 | US20060211715 Quinazoline protein tyrosine phosphatase inhibitors |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | US20060211577 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | CA2601425A1 Novel dihydropyrimidine derivatives and their use as anti-cancer agents |
| 09/21/2006 | CA2601257A1 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/21/2006 | CA2600868A1 Quinazolinone t-type calcium channel antagonists |
| 09/21/2006 | CA2600763A1 Use of 2 -anilino - 3 , 4 -dihydro - quinazolines as 5ht5a receptor antagonists |
| 09/21/2006 | CA2600681A1 Pyrimidine carboxylic acid derivatives and use thereof |
| 09/20/2006 | EP1702917A1 Amide derivative and medicine |
| 09/20/2006 | EP1701952A1 Dutpase inhibitors |
| 09/20/2006 | EP1701946A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/20/2006 | EP1701944A2 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases |
| 09/20/2006 | EP1701727A1 Dutpase inhibitors |
| 09/20/2006 | EP1366027B1 Combi-molecules having signal transduction inhibitory properties and dna damaging properties |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | CN1835931A Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CFR antagonists |
| 09/20/2006 | CN1835930A Process for producing pyrimidin-4-one compound |
| 09/20/2006 | CN1835929A 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 09/20/2006 | CN1835928A Pyrimidinone compounds as calcilytics |
| 09/20/2006 | CN1835753A Spiro tetrahydroquinazolines and dihydrocyclopentapyrimidines as CFR antagonists |
| 09/20/2006 | CN1275965C Derivatives of variolin b |
| 09/20/2006 | CN1275964C 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 09/20/2006 | CN1275947C Nitrogen-contg. heterocyclic carboxamide derivatives or salt thereof |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/19/2006 | US7109364 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 09/19/2006 | US7109336 Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same |
| 09/19/2006 | US7109333 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 09/19/2006 | US7109243 Inhibitors of cathepsin S |
| 09/19/2006 | US7109224 Acyl guanidine compounds and use thereof |
| 09/19/2006 | US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 09/19/2006 | US7109203 for use in the treatment or prevention of diseases in which bradykinin B1 receptor activation plays a role |
| 09/19/2006 | US7109148 Using an acylurea compound containing pyrimidine ring |